InnoCare Gets OK to Trial Mesutoclax for MDS in China
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND)...
Category : Healthcare and Pharmaceutical
BeOne Medicines Launches After Move to Switzerland
BeOne Medicines Ltd., a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially in effect,...
IonOpticks Gen 4 Aurora Sets New Benchmark in Chromatography
IonOpticks, developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive...
CPHI & PMEC China Sees Surge in Global Pharma Attendance
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth CPHI & PMEC China returns to the Shanghai...
Alamar Biosciences Partners with SciLifeLab to Advance Disease Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration with SciLifeLab to advance...
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment of Vibha Jawa, PhD, FAAPS as Chief Scientific...
ISSA Launches GLP-1 Training for New Weight Loss Coaching Era
The International Sports Sciences Association (ISSA) has announced the launch of its comprehensive GLP-1 Weight Loss Support Training, designed to equip personal trainers, health coaches, and fitness...
Evidently Hires Andrés Krogh-Walker as Head of Marketing
The clinical data intelligence platform continues executive team expansion following $15 million funding round Clinical data intelligence platform has tapped Andrés Krogh-Walker as its head of...
Stride & UNITY Fitness Announce Market-First Partnership in Canada
Industry-leading debut of Canada’s most advanced health and wellness model that combines advanced health diagnostics with a premium fitness and recovery membership experience. In a...
Foundation Medicine Adds MET Testing to IHC Portfolio
Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC...
Covalon Launches New Clinical Research on VALGuard Vascular Guard
Study results have been selected for presentation at two prestigious scientific meetings and are advancing to publication Covalon Technologies Ltd., an advanced medical technologies company,...
Study Shows Ambry Genetics’ Program Impact on Rare Disease Diagnosis
Peer-reviewed publication examines the benefits of proactive exome reanalysis on diagnostic outcomes Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc., and a leader...
PeproMene, IFLI: First FL Patient on BAFF-R CAR-T Sees Complete Response
PeproMene Bio, Inc. (PMB) a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first r/r FL patient treated...
Mazdutide Obesity Study in China Published in NEJM
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and...
XellSmart’s iPSC Therapy for Spinal Injury Approved for FDA Trial
In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy has received official approval from both China’s National...